Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Zilretta (triamcinolone acetonide extended-release injectable suspension) for the Treatment of Osteoarthritis Knee Pain

Drug (Brand / Generic)

Zilretta™ / triamcinolone acetonide extended-release injectable suspension

Developer

Flexion Therapeutics

Therapy Class

Triamcinolone acetonide

Current Indication

Osteoarthritis knee pain

Market Sector

Rheumatology

Development Status

Approved in the US
Expand

Go Top